Feature

Odanacatib reduced fractures but upped stroke risk

Publish date: October 19, 2016

 

FROM THE NAMS 2016 ANNUAL MEETING

On Twitter @karioakes

Pages

Recommended Reading

Start time for estrogen conveys no cognitive impact
MDedge ObGyn
Does extending aromatase-inhibitor use from 5 to 10 years benefit menopausal women with hormone-positive breast cancer?
MDedge ObGyn
Decision rule identifies unprovoked VTE patients who can halt anticoagulation
MDedge ObGyn
Hot flashes and sleep disruption contribute independently to depression in menopause
MDedge ObGyn
Letter to the Editor: Menopause and HT
MDedge ObGyn
Breast arterial calcifications predict atherosclerotic cardiovascular events
MDedge ObGyn
NAMS 2016 hormone therapy position statement
MDedge ObGyn
When is it time to stop hormone therapy?
MDedge ObGyn
Novel fractional laser eased genitourinary syndrome of menopause
MDedge ObGyn
Early menopause a risk factor for type 2 diabetes
MDedge ObGyn